830 related articles for article (PubMed ID: 16688182)
1. IL-23 promotes tumour incidence and growth.
Langowski JL; Zhang X; Wu L; Mattson JD; Chen T; Smith K; Basham B; McClanahan T; Kastelein RA; Oft M
Nature; 2006 Jul; 442(7101):461-5. PubMed ID: 16688182
[TBL] [Abstract][Full Text] [Related]
2. Swords into plowshares: IL-23 repurposes tumor immune surveillance.
Langowski JL; Kastelein RA; Oft M
Trends Immunol; 2007 May; 28(5):207-12. PubMed ID: 17395538
[TBL] [Abstract][Full Text] [Related]
3. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells.
Hoeve MA; Savage ND; de Boer T; Langenberg DM; de Waal Malefyt R; Ottenhoff TH; Verreck FA
Eur J Immunol; 2006 Mar; 36(3):661-70. PubMed ID: 16482511
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.
Zheng Y; Danilenko DM; Valdez P; Kasman I; Eastham-Anderson J; Wu J; Ouyang W
Nature; 2007 Feb; 445(7128):648-51. PubMed ID: 17187052
[TBL] [Abstract][Full Text] [Related]
5. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
6. T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression.
Kleinschnitz C; Hofstetter HH; Meuth SG; Braeuninger S; Sommer C; Stoll G
Exp Neurol; 2006 Aug; 200(2):480-5. PubMed ID: 16674943
[TBL] [Abstract][Full Text] [Related]
7. Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumour cells: mechanisms of tumour rejection and immunotherapeutical implications.
Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Huleihel M; Fima E; Hacham M; Voronov E
Folia Biol (Praha); 1994; 40(1-2):1-18. PubMed ID: 7958060
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.
Yuan X; Hu J; Belladonna ML; Black KL; Yu JS
Cancer Res; 2006 Mar; 66(5):2630-8. PubMed ID: 16510582
[TBL] [Abstract][Full Text] [Related]
9. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17.
Rangachari M; Mauermann N; Marty RR; Dirnhofer S; Kurrer MO; Komnenovic V; Penninger JM; Eriksson U
J Exp Med; 2006 Aug; 203(8):2009-19. PubMed ID: 16880257
[TBL] [Abstract][Full Text] [Related]
10. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
11. The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth?
Olver S; Apte S; Baz A; Kienzle N
Tissue Antigens; 2007 Apr; 69(4):293-8. PubMed ID: 17389011
[TBL] [Abstract][Full Text] [Related]
12. Immune enhancement and anti-tumour activity of IL-23.
Hao JS; Shan BE
Cancer Immunol Immunother; 2006 Nov; 55(11):1426-31. PubMed ID: 16676182
[TBL] [Abstract][Full Text] [Related]
13. Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery.
Kowalczyk A; Wierzbicki A; Gil M; Bambach B; Kaneko Y; Rokita H; Repasky E; Fenstermaker R; Brecher M; Ciesielski M; Kozbor D
Cancer Immunol Immunother; 2007 Sep; 56(9):1443-58. PubMed ID: 17597331
[TBL] [Abstract][Full Text] [Related]
14. HPV 16-associated tumours: IL-12 can repair the absence of cytotoxic and proliferative responses of tumour infiltrating cells after chemotherapy.
Indrová M; Bieblová J; Rossowska J; Kuropka P; Pajtasz-Piasecka E; Bubeník J; Reinis M
Int J Oncol; 2009 Jan; 34(1):173-9. PubMed ID: 19082488
[TBL] [Abstract][Full Text] [Related]
15. In situ vaccination against a non-immunogenic tumour using intratumoural injections of liposomal interleukin 2.
Neville ME; Robb RJ; Popescu MC
Cytokine; 2001 Dec; 16(6):239-50. PubMed ID: 11884028
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors.
Søndergaard H; Frederiksen KS; Thygesen P; Galsgaard ED; Skak K; Kristjansen PE; Odum N; Kragh M
Cancer Immunol Immunother; 2007 Sep; 56(9):1417-28. PubMed ID: 17285290
[TBL] [Abstract][Full Text] [Related]
17. IL-12 and IL-23: master regulators of innate and adaptive immunity.
Langrish CL; McKenzie BS; Wilson NJ; de Waal Malefyt R; Kastelein RA; Cua DJ
Immunol Rev; 2004 Dec; 202():96-105. PubMed ID: 15546388
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells.
Chiyo M; Shimozato O; Iizasa T; Fujisawa T; Tagawa M
Anticancer Res; 2004; 24(6):3763-7. PubMed ID: 15736409
[TBL] [Abstract][Full Text] [Related]
19. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response.
Rodrigues L; Nandakumar S; Bonorino C; Rouse BT; Kumaraguru U
Mol Immunol; 2009 Apr; 46(7):1494-504. PubMed ID: 19233474
[TBL] [Abstract][Full Text] [Related]
20. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4.
Watford WT; Hissong BD; Bream JH; Kanno Y; Muul L; O'Shea JJ
Immunol Rev; 2004 Dec; 202():139-56. PubMed ID: 15546391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]